Using murine and patient-derived DCs we show that NDV efficiently induces cDC1 activation and tumor Ag cross-presentation, and that Flt3L induces robust amplification of tumor-specific T cell responses and long-term tumor control. This evidence concerns the gene FLT3LG and neoplasm.